
The company's second-quarter results caused a major rally in the stock.
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

The company's second-quarter results caused a major rally in the stock.

Boeing hands over three subsidiaries and walks away owning about 16.5% of Archer. Insitu alone brings annual revenue 29 times Archer's own.

If Wall Street is right, it's a no-brainer buy now.

Arista trades at a steep premium to IBM, but their growth trajectories and risk profiles tell very different stories for 2026 investors.

In the June quarter, Boston Scientific completed a share repurchase of 39,922,436 shares, equal to 2.69% of its stock, for US$2,000.11 million under the buyback first announced in December 2020, while quarterly results highlighted underperformance in U.S. Electrophysiology and Watchman alongside lower 2026 organic sales growth guidance. Although the CHAMPION-AF trial met all clinical endpoints, it did not act as a meaningful catalyst for the business outlook, and the contrast between bullish...

Networking technology giant Cisco (NASDAQ:CSCO) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 17.6% year on year to $17.25 billion. On top of that, next quarter’s revenue guidance ($18.1 billion at the midpoint) was surprisingly good and 8.1% above what analysts were expecting. Its non-GAAP profit of $1.22 per share was 4.4% above analysts’ consensus estimates.

Shareowners have larger dividends headed their way.

No day is a dull one when talking about SanDisk (SNDK). We have had lots of interesting positive angles before. On Thursday, Aug. 13, SanDisk gave investors something bigger than a quarterly beat or an analyst upgrade. It gave them a long-term financial model. And of course, the market had to ...

On August 11, medtech leader Abbott Laboratories (NYSE:ABT) and tech behemoth Alphabet Inc. (NASDAQ:GOOG) announced a multi-year partnership to unite continuous glucose monitoring with consumer AI. The collaboration embeds data from Abbott’s non-prescription Lingo biowearable directly into the Google Health app, combining real-time metabolic insights with Google’s AI Health Coach to deliver personalized habit recommendations […]

Commerce Secretary Howard Lutnick urged the iPhone maker to find other solutions to the artificial-intelligence-driven chip supply crunch.

After a dramatic weekly rally, a caller on the August 11 episode of CNBC’s Mad Money pointed out the rapid trajectory of Palantir Technologies Inc. (NASDAQ:PLTR). The caller noted that the stock had jumped 44.1% in less than a week and appeared to face virtually no direct competition in its specialized enterprise software space. Jim […]

This automatic tax withholding tied to RSU vesting reduced Min's direct holdings by 27%, though he retains 39,059 shares and close to 100,000 derivative units.

Shares withheld from RSU vesting reduced this insider's direct equity stake.

Best Buy’s 28.9% return over the past six months has outpaced the S&P 500 by 15.4%, and its stock price has climbed to $83.62 per share. This performance may have investors wondering how to approach the situation.

Insider Lindsay Radkoski executed a non-discretionary sale tied to restricted stock unit vesting, reducing direct holdings by 12%. She retains 61,207 shares and 101,828 derivative securities.

The healthcare technology leader is using artificial intelligence to detect coronary artery disease early.

This insider withheld shares to cover tax obligations from restricted stock unit vesting, reducing direct equity by 13% while maintaining a substantial position of 131,764 shares.
Gemini Space Station Inc (GEMI) reports record services revenue and cost cuts, yet faces headwinds from a 66% drop in spot trading volume and a $20.1 million fraud-related provision.

On July 29, AbCellera Biologics Inc. (NASDAQ:ABCL) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced a strategic collaboration to research, develop, and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases. Under the agreement, AbCellera will leverage its proprietary TCE platform to lead discovery, while Vertex will fund all research and development and retain commercialization rights. In return, […]

Intel once was the biggest chipmaker in the world. During the 1990s through the mid-2010s, Intel’s semiconductor powered most of the personal computers in businesses and homes worldwide. Nowadays, the company is playing catch-up, competing with other powerful players in the semiconductor industry — ...

They are way more than just GLP-1 stocks.

Capital Southwest trades at $25.05 per share and has stayed right on track with the overall market, gaining 8.6% over the last six months. At the same time, the S&P 500 has returned 13.5%.

Amazon's $77.7 billion net income and 10.8% margin showcase profitability at scale, while StubHub's $191 million free cash flow points to a path back from recent losses.

In recent days, analysts have reinforced a positive stance on Comfort Systems USA, with an average brokerage recommendation near Buy to Strong Buy and a Zacks Rank #1 (Strong Buy) supported by upward revisions to earnings estimates. What stands out is that Comfort Systems USA’s projected earnings-per-share growth rate is set well above its industry peers, reflecting especially strong optimism around the company’s earnings outlook. We’ll now examine how these upward earnings revisions and...

Investors are mining below the headline numbers, and they dig what they discovered.

What a brutal six months it’s been for American Eagle. The stock has dropped 28.6% and now trades at $17.51, rattling many shareholders. This may have investors wondering how to approach the situation.

Palantir surged and PLTY holders collected a strong return, but a quiet structural trade-off inside the fund quietly kept some of that rally out of reach. Understanding exactly what you own changes how you should think about the yield.

The market may be focused on temporary hurdles, but a strategic acquirer would see a unique technology at a strong price.

Over the past six months, Genuine Parts’s shares (currently trading at $135.19) have posted a disappointing 8.4% loss, well below the S&P 500’s 13.5% gain. This might have investors contemplating their next move.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.